» Articles » PMID: 29866644

Digital Health Intervention for Asthma: Patient-Reported Value and Usability

Overview
Date 2018 Jun 6
PMID 29866644
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although digital health tools are increasingly recognized as effective in improving clinical outcomes such as asthma control and medication adherence, few studies have assessed patient experiences and perception of value.

Objective: The aim of this study was to evaluate patient satisfaction, perception of usability and value, and desire to continue after 12 months of using a digital health intervention to support asthma management.

Methods: Participants were enrolled in a randomized controlled study evaluating the impact of a digital health platform for asthma management. Participants used electronic inhaler sensors to track medication use and accessed their information in a digital health platform. Electronic surveys were administered to intervention arm participants aged 12 years and older after 12 months of use. The survey assessed asthma control, patient satisfaction with the sensor device, and perception of the usability and value of the digital health platform through closed-ended and open-ended questions. Logistic regression models were used to assess the impact of participants' characteristics on survey completion, satisfaction, and perception of value.

Results: Of the 207 intervention arm participants aged 12 years and older, 89 submitted survey responses (42.9% response rate). Of these 89 participants, 70 reported being very satisfied (79%, 70/89) or somewhat satisfied (20%, 18/89) with the inhaler sensor device. Moreover, 93% (83/89) expressed satisfaction with the reports, and 90% (80/89) found the information from the reports useful for learning about their asthma. In addition, 72% (64/89) of the participants reported that they were interested in continuing to use the sensor and platform beyond the study. There were no significant differences in satisfaction with the device or the platform across participants' characteristics, including device type, age, sex, insurance type, asthma control, or syncing history; however, participants with smartphones and longer participation were more likely to take the survey.

Conclusions: Electronic sensors and a digital health platform were well received by participants who reported satisfaction and perceived value. These results were consistent across multiple participants' characteristics. These findings can add to a limited literature to keep improving digital health interventions and ensure the meaningful and enduring impact on patient outcomes.

Citing Articles

Objective detection of wheeze at home by parents through a digital device: usage patterns and relationship with SABA administration.

Do Y, van Aalderen W, Dellbrugger E, Grenzbach C, Grigg J, Grittner U Pediatr Pulmonol. 2024; 60(1):e27295.

PMID: 39451025 PMC: 11715141. DOI: 10.1002/ppul.27295.


iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control.

Castro M, Zavod M, Rutgersson A, Jornten-Karlsson M, Dutta B, Hagger L J Asthma Allergy. 2024; 17:653-666.

PMID: 39011068 PMC: 11247342. DOI: 10.2147/JAA.S458618.


Impact of a digital web-based asthma platform, a real-life study.

Genberg E, Viitanen H, Makela M, Kautiainen H, Kauppi P BMC Pulm Med. 2023; 23(1):165.

PMID: 37173716 PMC: 10177708. DOI: 10.1186/s12890-023-02467-8.


Clinical Impact of Electronic Monitoring Devices of Inhalers in Adults with Asthma or COPD: A Systematic Review and Meta-Analysis.

Garin N, Zarate-Tamames B, Gras-Martin L, Mila R, Crespo-Lessmann A, Curto E Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986513 PMC: 10055893. DOI: 10.3390/ph16030414.


Will they or won't they? Understanding New Zealand adults' attitudes towards using digital interventions.

Wilson H, Hayward P, Donkin L Front Digit Health. 2023; 5:1008564.

PMID: 36969957 PMC: 10030707. DOI: 10.3389/fdgth.2023.1008564.


References
1.
Huckvale K, Morrison C, Ouyang J, Ghaghda A, Car J . The evolution of mobile apps for asthma: an updated systematic assessment of content and tools. BMC Med. 2015; 13:58. PMC: 4391129. DOI: 10.1186/s12916-015-0303-x. View

2.
Cook K, Modena B, Simon R . Improvement in Asthma Control Using a Minimally Burdensome and Proactive Smartphone Application. J Allergy Clin Immunol Pract. 2016; 4(4):730-737.e1. PMC: 5501988. DOI: 10.1016/j.jaip.2016.03.005. View

3.
Howard S, Lang A, Sharples S, Shaw D . What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective. BMJ Open Respir Res. 2016; 3(1):e000159. PMC: 5133420. DOI: 10.1136/bmjresp-2016-000159. View

4.
Barnett S, Nurmagambetov T . Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011; 127(1):145-52. DOI: 10.1016/j.jaci.2010.10.020. View

5.
OConnor S, Hanlon P, ODonnell C, Garcia S, Glanville J, Mair F . Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Med Inform Decis Mak. 2016; 16(1):120. PMC: 5024516. DOI: 10.1186/s12911-016-0359-3. View